martin shkreli
Sponsored by
PUBLIC GOODSA law professor’s big idea for combatting greedy drug company titans like Martin ShkreliSeptember 21, 2017 • Quartz
WHAT A SMIRKPharma bro Martin Shkreli is convicted for a securities fraud scheme that’s eerily familiarAugust 4, 2017 • Quartz
ART IMITATES LIFE?Detested pharma bro Martin Shkreli is going to trial, and America made a musical out of itMay 18, 2017 • Quartz
WHO, ME?Watch and learn, Milo: At Harvard, the “most hated man in America” gives a master class in trollingFebruary 16, 2017 • Quartz
PRESS PLAYWell, at least Trump’s win means we get Martin Shkreli’s $2 million Wu-Tang Clan albumNovember 9, 2016 • Quartz
NO FEAREven Elizabeth Warren’s fury can’t shame America’s CEOsSeptember 23, 2016 • Quartz
PORE DECISIONThe newest pharma villain Novum is charging $9,561 for a tube of skin creamSeptember 21, 2016 • Quartz
EMERGENCY INJECTIONThe maker of the wildly expensive EpiPen came up with a cheaper version over the weekendAugust 29, 2016 • Quartz
THE ART OF THE DEALHow the publishing industry repackages privilege into compelling Horatio Alger storiesJuly 22, 2016 • Quartz
OVERHEADMartin Shkreli is no longer the one to blame for the $750-a-pill AIDS medicationFebruary 6, 2016 • Quartz